[Featured Stock] Genome Analysis Technology Platform Company Selemix Hits Upper Limit
Genome analysis technology platform company Selemix is hitting the upper price limit.
As of 9:06 AM on the 12th, Selemix is trading at 5,200 KRW on the KOSDAQ market, up 1,200 KRW (30%) from the previous trading day.
Selemix has developed the next-generation cloning technology MSSIC and three productization technologies, conducting businesses in Target Capture kits, immune repertoire analysis solutions, and next-generation sequencing solutions.
It supplies products to major institutions in the bio industry such as hospitals, contract testing organizations, pharmaceutical companies, seed companies, and research institutes.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
It is used as an essential material to create value in a wide range of fields including diagnostics, new drug development, seed development, synthetic biology, microbiome, and academic research.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.